MissionIR Articles
Original content written and distributed as part of our ongoing relationships.
-
MissionIRNewsBreaks – D-Wave Quantum Inc.’s (NYSE: QBTS) Trailblazing Efforts in Quantum Market Featured in Bell2Bell Podcast
D-Wave (NYSE: QBTS), a leader in quantum computing systems, software and services, was featured in the Bell2Bell Podcast, a part of IBN’s (“InvestorBrandNetwork”) sustained effort to provide specialized content distribution via widespread syndication channels. Dr.…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Recognized for Strategic M&A Objectives at Benzinga Cannabis Capital Conference
Flora (NASDAQ: FLGC) is a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands. The company today announced its receipt of the Best M&A Deal award at Benzinga’s 2022 Cannabis Capital Conference…
-
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Takes Aim at Thus-far Incurable GBM Brain Cancer with Human Drug Trials
U.S.-based drug innovator CNS Pharmaceuticals is enrolling patients in a global clinic trial to evaluate the performance of the company’s lead drug candidate, Berubicin, in fighting glioblastomas Glioblastoma is an incurable brain cancer that is…
-
Flora Growth Corp. (NASDAQ: FLGC), Cannabis Brand Builder, is Ramping Up its HR Productivity and Effectiveness One Appointment at a Time
A 2017 study by McKinsey & Company showed that high performers tend to be 400% more productive than average ones. This outlook has shaped Flora Growth’s hiring strategy for 2022, with the appointment of several…
-
MissionIRNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Eyes Opportunity Across 4 Key Areas, Untapped Market in China
FingerMotion (NASDAQ: FNGR), a leader in mobile payment and recharge platform solutions in China, has consistently reinvented itself and adjusted to changing customer preferences. “Today, its goal remains to serve over a billion users in…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Enters into $6M Securities Purchase Agreement
InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids, has announced a private placement agreement with two healthcare-focused institutional investors. The agreement calls for the issuance and sale of…
-
MissionIRNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Acquisition of Controlling Stake in Bollinger Motors Featured in Recent Articles
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, was featured in recent articles published by InsideEVs and Newsweek that discussed its strategic move to purchase a controlling stake in Bollinger Motors. “EV fresh…
-
FingerMotion Inc. (NASDAQ: FNGR) Taking Advantage of 5G’s Proliferation in China to Grow Market Share
FingerMotion launched its mobile device protection service on July 15, 2022, banking on the transition to and the proliferation of 5G within the Chinese market With the Chinese government targeting over 2 million 5G base…
-
Cepton, Inc. (NASDAQ: CPTN) ‒ Experts Confirm Lidar Technology Provides Superior Automotive Safety Compared to Camera-only Systems
Consensus among autonomous vehicle experts increasingly lean in favor of implementing lidar solutions to promote AV safety HD cameras only provide raw image data in 2D; lidar uses laser technology to determine exact distance and…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Acquires 27th Worldwide Patent Applying to a Range of APIs in Ready-to-Drink Consumer Retail Beverage Products
Lexaria’s Mexican patent “Stable Ready-to-Drink Beverage Compositions Comprising Lipophilic Active Ingredients” joins the ranks of previously issued patents in Australia, India, Japan and the EU The patent allows the company to provide value in gaining…
-
MissionIRNewsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Plans Participation in Key Global Events During September, October
Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has released its upcoming event schedule; the company plans to participate in eight events during the coming weeks. The schedule includes key…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) CEO Releases Shareholder Statement in Response Bollinger Motors Majority Acquisition
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is updating shareholders about the company’s recent majority acquisition of Bollinger Motors Inc. MULN CEO and chair David Michery released a statement for shareholders providing…
-
MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Expands KCM Relationship to Meet Needs for US/Mexico Cross-Border Traffic
Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company based on its custom-developed and AI- and machine learning-powered Fr8App platform, which offers a real-time portal for B2B cross-border shipping and domestic shipping within the United…
-
MissionIRNewsBreaks – Cerberus Cyber Sentinel Corp. (NASDAQ: CISO) Appoints Seasoned Veteran as M&A Legal Counsel
Cerberus Cyber Sentinel (NASDAQ: CISO), a managed compliance and cybersecurity provider, has named a mergers and acquisitions (“M&A”) legal counsel. The company announced that David Bronner will be serving in the role, overseeing all legal…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Update on Company Objectives and Programs
InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids and cannabinoid analogs, is reporting an update on the company’s research/development and commercial activities. According to the update, the company…
-
Upgrades to Big Data Analysis Division Positions FingerMotion Inc. (NASDAQ: FNGR) for New Growth Era in China
U.S.-based communications technology services provider FingerMotion recently announced a number of milestones in its drive to make its Sapientus big data arm a powerful driver of analytics in China’s billion-strong consumer marketplace The company has…
-
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Efforts to Combat GBM Brain Cancer Proceed Amid Competitive Field
CNS Pharmaceuticals, a Texas-based cancer drug developer, is advancing testing efforts for its lead drug candidates in the fight against glioblastoma (“GBM”) and other tumors Glioblastoma is an aggressive brain cancer that claims the lives…
-
MissionIRNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Robot Roadshow to Take the Spotlight at Underground Atlanta
Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced that its Robot Roadshow will land at Underground Atlanta in Georgia from 10 a.m. to 8 p.m.…
-
MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) on Leading Edge of Psilocybin Research
Cybin (NYSE American: CYBN) (NEO: CYBN) is a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions. The company is on the leading edge of a transformation that has…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) ‘Heralding Next Wave of Computing’
D-Wave (NYSE: QBTS) is a leader in quantum computing systems, software and services. Positioned as the only company building both quantum annealing and gate-based quantum computers, D-Wave is committed to delivering customer value through practical…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces 1st EV Acquisition, Webinar to Discuss Strategic Move
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has announced its acquisition of a controlling interest in EV truck innovator Bollinger Motors Inc. This is Mullen’s first EV acquisition and propels the company…
-
MissionIRNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Achieves Record Revenues, 16th Consecutive Quarter of Profitability
Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of gaming platforms, systems and gaming content, today announced financial results for its third fiscal quarter ended July 31, 2022. Among the highlights, the company reported…
-
Cepton, Inc.’s (NASDAQ: CPTN) Short-Range Lidar Nova Aims to Eliminate Blind Spots for Autonomous Vehicles; Plans to Exhibit Tech During IAA Transportation Conference
Cepton, in collaboration with ZKW Group GmbH, plans to showcase its Nova lidar headlamp integration into a ZKW heavy-duty truck headlamp at the IAA Transportation Conference (Sept. 20-25, 2022) Nova is an award-winning, miniature, wide…
-
Flora Growth Corp. (NASDAQ: FLGC) Names New CFO, Process for Ensuring Smooth Transition Amid Company’s Global Growth
Global cannabis brand-builder Flora Growth recently named a former Amazon financial executive as its new CFO Elshad Garayev will work with outgoing CFO Lee Leiderman to ensure a smooth transition of responsibility amid finalization of…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at H.C. Wainwright 24th Annual Global Investment Conference
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that its CEO John Climaco will present…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Subsidiary Announces Acquisition of Emerging Hemp Flower Market Brand
Flora Growth (NASDAQ: FLGC), an all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced that its wholly owned subsidiary, Just Brands LLC, has acquired substantially all of the assets related to the…
-
MissionIRNewsBreaks – EverGen Infrastructure Corp.’s (TSX.V: EVGN) (OTCQB: EVGIF) Upside Potential Featured in Seeking Alpha Article
EverGen (TSX.V: EVGN) (OTCQB: EVGIF) was featured in a recent Seeking Alpha article describing its positioning to take advantage of tremendous opportunities as the world shifts to renewable energy sources to fight climate change and…
-
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Posts Slight Q2 2022 Performance Improvement; Maintains Priorities and Focus on Advancing its Clinical Development Program for Berubicin
CNS reported a decrease in losses from $3.8 million in Q2 2021 to $3.6 million in Q2 2022, as well as a drop in research and development expenses from $2.7 million to $2.2 million, with…
-
FingerMotion Inc. (NASDAQ: FNGR) Benefitting From a First-Mover Advantage, and Relationships Forged in the Chinese Market
Martin Shen, FingerMotion’s CEO, noted the company’s shift in focus to pushing gross margins higher for the 2022 calendar year This has shaped the company’s initiatives that have seen the addition of the mobile device…
-
MissionIRNewsBreaks – Cerberus Cyber Sentinel Corporation (NASDAQ: CISO) Accelerates Growth Strategy into Latin America Through Strategic Acquisition
Cerberus Sentinel (NASDAQ: CISO), an industry leader as a managed cybersecurity and compliance provider based in Scottsdale, Arizona, today announced that it has completed the acquisition of NLT Secure. Under the agreement, the cybersecurity company…
-
Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Quest to Find Hypertension Treatment Promising With DehydraTECH(TM)’s Ability to Boost Bioavailability
Lexaria, a global innovator of drug delivery platforms is looking to provide a FDA registered hypertension treatment with its patented DehydraTECH technology The company’s efforts are encapsulated in its DehydraTECH-CBD that has been shown to…
-
MissionIRNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Pioneering RNG Efforts, Growing Footprint
EverGen (TSX.V: EVGN) (OTCQB: EVGIF), a leading Canadian renewable energy company and Canada’s renewable natural gas (“RNG”) infrastructure platform, is pioneering RNG efforts across three provinces. “In only a few years since its founding, EverGen…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints New Board Member
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has announced an addition to its board of directors; the company named industry veteran Catherine Turkel, PharmD, PhD, as the newest member of its board.…
-
B2B iGaming Leader Golden Matrix Group Inc. (NASDAQ: GMGI) To Enter B2C Market with Recent Permit Approval
GMGI acquired 80% stake in RKings social gaming platform that earned $32 million in revenue and $2.6 million in net income during fiscal 2021 Permit application for Mexico approved others to follow as more governments…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Partners with Watergen on Game-Changing Technology
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced a signed partnership with Watergen Inc. Under the collaboration, Watergen, a pioneering Israel-based company and a global leader in the atmospheric drinking water…
-
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), Moving the Needle in GBM and Brain Cancer Research
When CNS went public in 2019, the funds went primarily into pre-clinical preparation, trial design approval, and drug manufacturing for its potentially pivotal global clinical trial of Berubicin for recurrent glioblastoma multiforme (“GBM”) So far,…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces New Patent in Mexico
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is continuing to accumulate international patents; most recently the company received its 27th patent granted worldwide. Part of Lexaria’s third patent family — Stable Ready-to-Drink Beverage…
-
MissionIRNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Completes Key Launch in Continued Push to Increase Gross Margins
FingerMotion (NASDAQ: FNGR) recently launched its mobile device protection product, looking to tap into an industry valued at approximately $10.6 billion annually. “While appearing in an interview with the investor media outlet, Proactive, Martin Shen,…
-
MissionIRNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) Adelia Marks Final Development Milestone
Cybin (NYSE American: CYBN) (NEO: CYBN) is a biotechnology company focused on progressing Psychedelics to Therapeutics(TM). The company today announced that its wholly controlled subsidiary, Adelia Therapeutics Inc., has achieved the milestone identified as Y2,…
-
MissionIRNewsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Receives Planned $100M Investment from Long-Term Partner
Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has received a nonbinding letter of intent (“LOI”) outlining a planned investment of up to $100 million. Dated Aug. 29, 2022, the…
Search Articles
Latest Articles
- FAVO Capital Inc. (FAVO): When Private Credit Meets Real Estate Collateralization
- AI and the Copper Conundrum: How Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Fits into the Supply Equation
- Silvercorp Metals Inc. (NYSE-A/TSX: SVM) El Domo Environmental License Upheld as Ecuador’s Constitutional Court Dismisses Final Challenge
- NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative
- MissionIRNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Closes $6.9 Million Public Offering Including Full Over-Allotment Option